{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:25:01Z","timestamp":1790673901192,"version":"4.1.0"},"reference-count":30,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2021,4,16]]},"DOI":"10.1080\/10428194.2020.1855344","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T23:13:35Z","timestamp":1607642015000},"page":"1077-1087","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas"],"prefix":"10.1080","volume":"62","author":[{"given":"Nina D.","family":"Wagner-Johnston","sequence":"first","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Schuster","sequence":"additional","affiliation":[{"name":"Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"deVos","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, Santa Monica, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, University Claude Bernard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech J.","family":"Jurczak","sequence":"additional","affiliation":[{"name":"Maria Sklodowska-Curie National Research Institute of Oncology, Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-6327","authenticated-orcid":false,"given":"Andreas","family":"Viardot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Flinn","sequence":"additional","affiliation":[{"name":"Hematologic Malignancies Research Program, Sarah Cannon Research Institute\/Tennessee Oncology, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Weill Cornell Medical College, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Xing","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishanthan","family":"Rajakumaraswamy","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Gopal","sequence":"additional","affiliation":[{"name":"University of Washington\/Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24086"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.656103"},{"key":"CIT0005","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas version 6.2019; 2019; [cited 2019 Dec 4]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx"},{"key":"CIT0006","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphoma version 1.2020; 2019; [cited 2020 Jan 22]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx"},{"key":"CIT0007","unstructured":"EMA Committee for Medicinal Products for Human Use. Revlimid (lenalidomide). Summary of opinion; 2019. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/smop\/chmp-post-authorisation-summary-positive-opinion-revlimid-ii-107_en.pdf"},{"key":"CIT0008","unstructured":"US FDA. FDA approves lenalidomide for follicular and marginal zone lymphoma; 2019. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-lenalidomide-follicular-and-marginal-zone-lymphoma"},{"key":"CIT0009","unstructured":"EMA Product Information. Zydelig (idelalisib). Summary of product characteristics; 2019.\u00a0Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/zydelig-epar-product-information_en.pdf"},{"key":"CIT0010","volume-title":"Full prescribing information","author":"ZydeligTM (idelalisib) Tablets for Oral Use.","year":"2018"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00915"},{"issue":"1","key":"CIT0013","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cncr.24714","volume":"116","author":"Kahl BS","year":"2010","journal-title":"Cancer"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-378323"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx289"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8853"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-747345"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.3656"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-757740"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15149"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.10.008"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.5301\/TJ.5000679"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S133291"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.28"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.07.283"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501548"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3994"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14665"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01460"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2540"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2020.1855344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:38:21Z","timestamp":1697326701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2020.1855344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,4,16]]}},"alternative-id":["10.1080\/10428194.2020.1855344"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2020.1855344","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}